UK launch for first PUMA-approved drug
This article was originally published in Scrip
Executive Summary
ViroPharma's Buccolam (midazolam oromucosal solution) for the treatment of prolonged, acute convulsive seizures in paediatric patients from three months to 18 years has been launched in the UK, its first European market.